MRCS Part A: Short Best Answer - Lymphoreticular Pathology

Name: MRCS Part A: Short Best Answer - Lymphoreticular Pathology
Start: 2025-03-02T15:00:00+00:00
End: 2025-03-02T16:00:00+00:00

2nd Mar 2025

3:00 - 4:00pm (GMT)

Surgery

Pathology

2nd Mar 2025

3:00 - 4:00pm (GMT)

Hosted on MedAll

Attendance certificate available

This event has ended. Similar events

Free

ONLINE

Description

📍 Live on Medall.org

🔹 Description:

A high-yield session on lymphoreticular pathology, essential for MRCS Part A. Bring your questions and test your knowledge with interactive SBAs.

📌 Session Agenda:

Common lymphoreticular disorders: lymphoma, leukemia, and myeloproliferative diseases
Pathological features and staging of lymphoid malignancies
Diagnosis and management of Hodgkin's and non-Hodgkin's lymphoma
MRCS-style SBA discussion and Q&A

Summary

Attend our riveting session on "MRCS Part A: Short Best Answer - Lymphoreticular Pathology" live on Medall.org. This high-yield session covers common lymphoreticular disorders, pathological features and staging of lymphoid malignancies, and diagnosis and management of Hodgkin's and non-Hodgkin's lymphoma. This essential discussion includes MRCS-style short best answer (SBA) discussions and Q&As to test your knowledge and answer any questions you might have. Don't miss this essential learning opportunity for all medical professionals, especially those preparing for MRCS Part A.

Generated by MedBot

Learning objectives

Identify common lymphoreticular disorders such as lymphoma, leukemia, and myeloproliferative diseases, and discuss their pathology.
Understand the pathological features and staging of lymphoid malignancies.
Demonstrate competency in diagnosing and managing Hodgkin's and non-Hodgkin's lymphoma.
Demonstrate ability to apply knowledge in practical situations through MRCS-style SBA discussion.
Enhance their critical thinking and problem-solving skills through interactive Q&A sessions.

Generated by MedBot

4 people attended this event. Sign up today and join your colleagues at future events.

View all